Connect Biopharma Holdings (CNTB) Receivables (2023 - 2026)
Connect Biopharma Holdings (CNTB) posted Receivables of $32000.0 for Q1 2026, down 80.12% sequentially from $161000.0 in Q4 2025, and down 81.71% YoY from $175000.0 in Q1 2025.
Connect Biopharma Holdings (CNTB) Receivables (2023 - 2026) Analysis & Trends
Connect Biopharma Holdings has reported Receivables for 4 years, with the latest figure at $32000.0 in Q1 2026.
- Quarterly Receivables fell 81.71% year-over-year to $32000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $32000.0 (down 81.71% YoY) and the FY2025 annual result came in at $161000.0, down 84.68% from the prior year.
- Receivables declined to $32000.0 in Q1 2026 per CNTB's latest filing, from $161000.0 in the prior quarter.
- Over five years, Receivables peaked at $3.9 million in Q2 2024 and troughed at $32000.0 in Q1 2026.
- A 4-year average of $654375.0 and a median of $184000.0 in 2025 frame the typical range for Receivables.
- The sharpest annual moves came in 2024 and 2025: Receivables dropped 25.36% in 2024, then slumped 95.03% in 2025.
- Over 4 years, Receivables stood at $351000.0 in 2023, then decreased by 25.36% to $262000.0 in 2024, then plunged by 38.55% to $161000.0 in 2025, then slumped by 80.12% to $32000.0 in 2026.
- According to Business Quant data, Receivables over the past three periods registered $32000.0, $161000.0, and $174000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.81 Bn | 131.96 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 86.56 Bn | 78.56 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 65.72 Bn | 60.53 Bn | 1.37 Bn | 1.93 Bn |
| 4 | Moderna | 58.75 Bn | 53.61 Bn | 52.00 Mn | 160.00 Mn |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | 1.06 Bn |
| 6 | Alnylam Pharmaceuticals | 31.76 Bn | 28.45 Bn | 992.69 Mn | 912.74 Mn |
| 7 | BioNTech SE | 28.59 Bn | 10.19 Bn | 668.28 Mn | 1.09 Bn |
| 8 | Insmed | 27.63 Bn | 26.47 Bn | 358.27 Mn | 215.33 Mn |
| 9 | Royalty Pharma | 27.24 Bn | 26.40 Bn | - | - |
| 10 | Connect Biopharma Holdings | 143.69 Mn | 143.69 Mn | - | 2.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.96 Mn |
| Mar 31, 2026 | 32,000.00 |
| Dec 31, 2025 | 161,000.00 |
| Sep 30, 2025 | 174,000.00 |
| Jun 30, 2025 | 193,000.00 |
| Mar 31, 2025 | 175,000.00 |
| Dec 31, 2024 | 262,000.00 |
| Jun 30, 2024 | 3.89 Mn |
| Dec 31, 2023 | 351,000.00 |